Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome
NCT ID: NCT02800720
Last Updated: 2016-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Mindfulness Meditation on Fibromyalgia-Related Pain
NCT02581332
Fibromyalgia: Interventions for Pain and Mood Regulation
NCT02683278
Mindfulness-Based Stress Reduction Program as an Intervention in Patients With Fibromyalgia
NCT00106275
Mindfulness to Improve Functional Outcomes in Patients With Fibromyalgia or Central Sensitization
NCT03693274
Efficacy of Amygdala Retraining With Mindfulness (ART+MF) vs Compassion Therapy (CT) for the Treatment of Patients With Fibromyalgia
NCT02454244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims: To evaluate the effectiveness of Meditation Awareness Training (MAT) - an SG-MBI - for treating FMS.
Method: Adults with FMS will receive MAT or an active control intervention known as Cognitive-Behavioural Therapy for Groups. Assessments will be performed at pre-intervention, post-intervention, and follow-up phases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meditation Awareness Training
Target Intervention Arm:
8-week meditation intervention
Meditation Awareness Training
8 Week Meditation Intervention
Cognitive Behavioural Therapy for Groups
Active Comparator Arm:
8-week CBT-based intervention
Cognitive Behavioral Therapy for Groups
8 week intervention based on Cognitive Behavioral Theory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meditation Awareness Training
8 Week Meditation Intervention
Cognitive Behavioral Therapy for Groups
8 week intervention based on Cognitive Behavioral Theory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 65 years
* Able to read and write using the English language
* Available to complete an eight-week intervention and six-month follow-up assessment
Exclusion Criteria
* Changes in psychopharmacology type or dosage one-month prior to intervention
* Currently practicing mindfulness or meditation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nottingham Trent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Van Gordon
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Van Gordon
Role: PRINCIPAL_INVESTIGATOR
Nottingham Trent University
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Embedded Qualitative Study
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NTU-MATFMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.